Skip to content

Asthma Control Study

Digital Health Tool for Parental Management of Childhood Asthma -- Impact on Asthma Control Test Scores

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03304067
Enrollment
262
Registered
2017-10-06
Start date
2017-10-03
Completion date
2018-05-03
Last updated
2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Asthma

Brief summary

The Digital Health Tool for Parental Management of Childhood Asthma -- Impact on Asthma Control Test Scores Study is a 16 week, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Tueo Health program on asthma control as indicated by change in baseline and study end (week 16) score on the Childhood Asthma Control Test score (ages 6- under 12 years) and the Asthma Control Test (ages 12-17 years) in children with uncontrolled asthma as the primary study objective.

Interventions

BEHAVIORALTueo Program

The asthma management solution utilizes devices (2 to attach on the child's bed and 1 for data transmission), which collect various metrics for a tailored smartphone application experience. The smartphone application provides access to view metrics from the devices, educational and clinical context content, and an asthma coach.

Sponsors

Tueo Health
CollaboratorUNKNOWN
Evidation Health
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Parent has a child who is \> 6 and \< 17.5 years old * Parent reports child has a diagnosis of asthma * Child takes daily asthma controller medication * Child has used rescue inhaler (e.g.albuterol, ProAir, etc) or nebulizer at least 2 times per week in the past 4 weeks * Child sleeps on a toddler, single, or double bed by themselves * Child will live in the same home for the majority of the next 16 weeks * Parent is \> 18 years old

Exclusion criteria

* Child's asthma has been controlled over the past 4 weeks * Child has any of the following conditions: sleep apnea, congenital heart disease, cardiac arrhythmias, or any other heart abnormalities, neurologic conditions including seizures, cerebral palsy, muscular dystrophy, genetic conditions or developmental disorders, autism, other major medical condition * Child is currently pregnant * Child was born premature (earlier than 36 weeks) * Parent is not fluent in English * No in-home WiFi * Parent does not use an Android phone as their primary phone * In a household with an existing enrolled participant in the study, even for a different child (e.g. only one child in a household may have questions reported back to the researchers by their parent) * Lives in Hawaii or Alaska

Design outcomes

Primary

MeasureTime frameDescription
Change in ACT/C-ACT scoresBaseline and Week 16Change in ACT/C-ACT scores from baseline to study end

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026